Synergy CHC Corp (NASDAQ:SNYR), a marketer of health and wellness brands like FOCUSfactor and Flat Tummy, reported financial results for the fourth quarter and full year ended December 31, 2025. The company's performance fell significantly short of Wall Street's expectations, triggering a sharp negative reaction in pre-market trading.
Earnings and Revenue Miss
The core figures from the Q4 2025 report reveal a substantial deviation from analyst forecasts. The company reported a net loss, with revenue coming in well below the consensus estimate.
- Reported Q4 Revenue: $6.07 million
- Analyst Estimate for Q4 Revenue: $11.05 million
- Reported Q4 Non-GAAP EPS: -$0.31
- Analyst Estimate for Q4 Non-GAAP EPS: $0.01
This represents a revenue miss of approximately 45% and a significant earnings per share miss, shifting from an expected marginal profit to a notable loss for the quarter.
Market Reaction
The market's immediate response to the earnings release was decisively negative. In pre-market trading following the announcement, SNYR shares were down approximately 6.2%. This sell-off reflects investor disappointment with both the top-line weakness and the deeper-than-anticipated loss. The pre-market drop contrasts with the stock's relatively flat performance over the past month and week, indicating the earnings report was a distinct catalyst.
Press Release Summary
The company's press release, issued on April 1, 2026, announced the financial results for the period. While the full details of management's commentary are not provided in the summary, the headline figures themselves tell a clear story of underperformance against expectations for the final quarter of 2025. The release did not provide a specific financial outlook for the coming periods, which leaves investors to rely on external analyst projections.
Forward-Looking Estimates
Analyst estimates for Synergy CHC's future performance, compiled independently, provide a benchmark for the company's expected recovery path. These projections suggest analysts are forecasting a return to revenue growth in the coming year, though starting from a diminished base.
- Q1 2026 Estimates:
- Estimated Revenue: $10.47 million
- Estimated EPS: $0.046
- Full Year 2026 Estimates:
- Estimated Revenue: $50.47 million
- Estimated EPS: $0.316
The Q1 2026 revenue estimate of $10.47 million, if achieved, would represent a significant sequential increase from the reported Q4 2025 revenue of $6.07 million. The full-year estimate implies a substantial year-over-year growth trajectory is expected. Investors will likely scrutinize the company's ability to meet these upcoming quarterly estimates to rebuild confidence.
For a detailed review of Synergy CHC Corp's historical earnings and future analyst projections, you can view the Earnings History and Analyst Forecasts.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation to buy, sell, or hold any security, or an endorsement of any investment strategy. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.